ASP5286
ASP5286 is a novel non-immunosuppressive cyclophilin inhibitor for the research of HCV.
Product Specifications
CAS Number
935735-70-9
UNSPSC
12352209
Target
Cyclophilin; HCV
Type
Peptides
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/asp5286.html
Solubility
10 mM in DMSO
Smiles
O[C@@H]([C@](C(N[C@@](C(N([C@@H](C(N([C@@](C(N[C@H](C(N([C@H]1CC(C)C)C)=O)CC(C)C)=O)([H])[C@@H](C)OC)C)=O)C)C)=O)([H])[C@H](O)C)=O)([H])N(C([C@@H](N(C([C@@H](NC([C@@H](N(C([C@H](NC([C@@H](NC1=O)C)=O)C)=O)C)CC(C)C)=O)CC(C)C)=O)C)C(C)C)=O)C)[C@H](C)C/C=C/C
Molecular Formula
C62H111N11O14
Molecular Weight
1234.61
References & Citations
[1]Makino T, et al. Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV. Bioorg Med Chem Lett. 2020 Aug 15;30 (16) :127308.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1201666-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details MBS1201666-02 0.1 mg (E-Coli)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details MBS1201666-03 0.02 mg (Yeast)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details MBS1201666-04 0.1 mg (Yeast)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details MBS1201666-05 0.02 mg (Baculovirus)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details MBS1201666-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus cereus Protein ArsC (arsC)
Sign In for Pricing
View Details